Found: 8
Select item for more details and to access through your institution.
Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study.
- Published in:
- Nutrients, 2020, v. 12, n. 6, p. 1650, doi. 10.3390/nu12061650
- By:
- Publication type:
- Article
Differential expression of polyamine biosynthetic pathways in skin lesions and in plasma reveals distinct profiles in diffuse cutaneous leishmaniasis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-67432-5
- By:
- Publication type:
- Article
Resolvin D1 drives establishment of Leishmania amazonensis infection.
- Published in:
- Scientific Reports, 2017, p. 46363, doi. 10.1038/srep46363
- By:
- Publication type:
- Article
Effects of Standardized Brazilian Green Propolis Extract (EPP-AF®) on Inflammation in Haemodialysis Patients: A Clinical Trial.
- Published in:
- International Journal of Nephrology, 2022, p. 1, doi. 10.1155/2022/1035475
- By:
- Publication type:
- Article
From Patents to Progress: Genetic Algorithms in Harmonic Distortion Monitoring Technology.
- Published in:
- Energies (19961073), 2023, v. 16, n. 24, p. 8002, doi. 10.3390/en16248002
- By:
- Publication type:
- Article
Differential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Arginase I, polyamine, and prostaglandin E2 pathways suppress the inflammatory response and contribute to diffuse cutaneous leishmaniasis.
- Published in:
- 2015
- By:
- Publication type:
- journal article